Detalhe da pesquisa
1.
Plasma-derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors.
Haemophilia
; 29(2): 456-465, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516312
2.
Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2).
Haemophilia
; 28(5): 745-759, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689832
3.
[Acquired hemophilia A with reappearance of inhibitor 10 years after the completion of immunosuppressive therapy].
Rinsho Ketsueki
; 62(3): 186-189, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-33828012
4.
Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B.
Haemophilia
; 25(4): e247-e256, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168882
5.
[A Pediatric Case of Acquired Hemophilia A: The Usefulness of the Activated Partial Thromboplastin Time (APTT) Cross-Mixing Test for Early Diagnosis].
J UOEH
; 40(4): 331-337, 2018.
Artigo
em Japonês
| MEDLINE | ID: mdl-30568085
6.
ACTN1 mutations cause congenital macrothrombocytopenia.
Am J Hum Genet
; 92(3): 431-8, 2013 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23434115
7.
Thrombosis from a prothrombin mutation conveying antithrombin resistance.
N Engl J Med
; 366(25): 2390-6, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22716977
8.
The prevalence of neutralizing antibodies against adeno-associated virus capsids is reduced in young Japanese individuals.
J Med Virol
; 86(11): 1990-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24136735
9.
Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study.
Res Pract Thromb Haemost
; 6(7): e12825, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36320425
10.
The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs.
Mol Ther Methods Clin Dev
; 27: 404-414, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36381300
11.
Convenience Comparison Study of Reconstitution Devices for the Blood Coagulation Factor VIII Products Rurioctocog Alfa Pegol and Antihemophilic Factor (Recombinant).
Int J Gen Med
; 13: 1469-1476, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328757
12.
Bernard-Soulier syndrome due to compound heterozygosity for a novel glycoprotein Ibß mutation.
Acta Haematol
; 131(1): 46-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24051937
13.
Effect of transfusion on the venous blood lactate level in very low-birthweight infants.
Pediatr Int
; 51(3): 321-5, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19419500
14.
Correction to: Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations.
Int J Hematol
; 107(1): 123-124, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29149425
15.
Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations.
Int J Hematol
; 106(5): 704-710, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550352
16.
HLA-B polymorphism in Japanese HIV-1-infected long-term surviving hemophiliacs.
Viral Immunol
; 18(3): 500-5, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16212528
17.
The International Immune Tolerance Induction Study and its follow-up study on Japanese hemophilia A patients with inhibitors.
Int J Hematol
; 101(4): 362-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25690486
18.
[Acquired von Willebrand syndrome with autoimmune hemolytic anemia].
Rinsho Ketsueki
; 45(3): 223-7, 2004 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-15103936
19.
[Antiphospholipid antibodies in children with idiopathic thrombocytopenic purpura].
Rinsho Ketsueki
; 43(9): 821-7, 2002 Sep.
Artigo
em Japonês
| MEDLINE | ID: mdl-12412285
20.
Long-term follow-up of children with refractory immune thrombocytopenia treated with rituximab.
Int J Hematol
; 99(4): 429-36, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24609717